16-1207820-C-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_021098.3(CACNA1H):​c.3114C>G​(p.Phe1038Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000483 in 1,449,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. F1038F) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -2.36

Publications

5 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03458634).
BS2
High AC in GnomAdExome4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.3114C>G p.Phe1038Leu missense_variant Exon 15 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.3114C>G p.Phe1038Leu missense_variant Exon 15 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.3114C>G p.Phe1038Leu missense_variant Exon 15 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.3114C>G p.Phe1038Leu missense_variant Exon 15 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.3114C>G p.Phe1038Leu missense_variant Exon 15 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.3114C>G p.Phe1038Leu missense_variant Exon 15 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.3114C>G p.Phe1038Leu missense_variant Exon 15 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.3075C>G p.Phe1025Leu missense_variant Exon 15 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.3114C>G p.Phe1038Leu missense_variant Exon 15 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.3075C>G p.Phe1025Leu missense_variant Exon 15 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.3114C>G p.Phe1038Leu missense_variant Exon 15 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.3114C>G p.Phe1038Leu missense_variant Exon 15 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.3114C>G p.Phe1038Leu missense_variant Exon 15 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.3114C>G p.Phe1038Leu missense_variant Exon 15 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.3114C>G p.Phe1038Leu missense_variant Exon 15 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.3114C>G non_coding_transcript_exon_variant Exon 15 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.3114C>G non_coding_transcript_exon_variant Exon 15 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.3114C>G non_coding_transcript_exon_variant Exon 15 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*1027C>G non_coding_transcript_exon_variant Exon 15 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*2561C>G non_coding_transcript_exon_variant Exon 14 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.3114C>G non_coding_transcript_exon_variant Exon 15 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.3114C>G non_coding_transcript_exon_variant Exon 15 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.3114C>G non_coding_transcript_exon_variant Exon 15 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.3114C>G non_coding_transcript_exon_variant Exon 15 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.3114C>G non_coding_transcript_exon_variant Exon 15 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.3114C>G non_coding_transcript_exon_variant Exon 15 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.3114C>G non_coding_transcript_exon_variant Exon 15 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.3114C>G non_coding_transcript_exon_variant Exon 15 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.3114C>G non_coding_transcript_exon_variant Exon 15 of 35 ENSP00000518777.1
CACNA1HENST00000640028.1 linkn.*1027C>G 3_prime_UTR_variant Exon 15 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*2561C>G 3_prime_UTR_variant Exon 14 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000439
AC:
1
AN:
227616
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000308
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000483
AC:
7
AN:
1449812
Hom.:
0
Cov.:
33
AF XY:
0.00000555
AC XY:
4
AN XY:
720090
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33234
American (AMR)
AF:
0.0000232
AC:
1
AN:
43118
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25964
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38982
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84054
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52142
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5756
European-Non Finnish (NFE)
AF:
0.00000542
AC:
6
AN:
1106618
Other (OTH)
AF:
0.00
AC:
0
AN:
59944
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
ExAC
AF:
0.00000829
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Jan 14, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNA1H protein function. This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1038 of the CACNA1H protein (p.Phe1038Leu). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
0.015
DANN
Benign
0.61
DEOGEN2
Benign
0.063
T;.;.;.
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.065
N
LIST_S2
Benign
0.55
T;T;T;.
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.035
T;T;T;T
MetaSVM
Uncertain
-0.037
T
MutationAssessor
Benign
0.10
N;.;N;N
PhyloP100
-2.4
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.090
N;.;N;N
REVEL
Benign
0.26
Sift
Benign
1.0
T;.;T;T
Sift4G
Benign
0.79
T;.;T;T
Polyphen
0.0010
B;.;B;B
Vest4
0.14
MutPred
0.31
Gain of glycosylation at T1034 (P = 0.1901);.;Gain of glycosylation at T1034 (P = 0.1901);Gain of glycosylation at T1034 (P = 0.1901);
MVP
0.46
ClinPred
0.020
T
GERP RS
-5.9
Varity_R
0.032
gMVP
0.24
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374946880; hg19: chr16-1257820; API